Translational research in respiratory medicine group

The research group carries out scientific work centred on clinical and translational research in respiratory medicine, adopting a multidisciplinary approach aimed at improving the prevention, diagnosis, prognosis and treatment of respiratory diseases. Its main areas of research include the study of obstructive sleep apnoea and circadian health, chronic respiratory diseases - particularly COPD and bronchiectasis - and the long-term sequelae of acute respiratory distress syndrome and COVID-19. Furthermore, the group has a well-established track record in lung cancer screening using low-dose computed tomography, participating in international initiatives and developing projects focused on the identification of biomarkers, radiomics and the application of artificial intelligence tools to improve early detection and risk stratification. Its work integrates the clinical and phenotypic characterisation of patients with the study of pathophysiological and molecular mechanisms and biomarkers, incorporating digital monitoring technologies, wearable devices, computational analysis and predictive models. The group is committed to precision medicine and the development of personalised diagnostic and therapeutic strategies, promoting the transfer of scientific knowledge into clinical practice. All of this is underpinned by close collaboration between professionals from different disciplines and national and international centres, as well as active participation in competitive projects and research networks.